Hadar Marcus

Ness Ziona, M, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adults.

Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adults.

Journal: Vaccine

Published: February 05, 2025

Mind the Gap-A Perspective on Strategies for Protecting against Bacterial Infections during the Period from Infection to Eradication.

Mind the Gap-A Perspective on Strategies for Protecting against Bacterial Infections during the Period from Infection to Eradication.

Journal: Microorganisms

Published: April 27, 2023

Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.

Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 29, 2022

Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel®85 Protects K18-hACE2 Mice against Lethal Virus Challenge.

Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel®85 Protects K18-hACE2 Mice against Lethal Virus Challenge.

Journal: Vaccines

Published: October 14, 2022

rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.

rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.

Journal: Archives of toxicology

Published: March 16, 2022

Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera.

Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera.

Journal: Vaccines

Published: January 24, 2022

Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs.

Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs.

Journal: Archives of toxicology

Published: October 04, 2021

Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies.

Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies.

Journal: Antibodies (Basel, Switzerland)

Published: September 16, 2021

Ethics and execution of developing a 2nd wave COVID vaccine - Our interim phase I/II VSV-SARS-CoV2 vaccine experience.

Ethics and execution of developing a 2nd wave COVID vaccine - Our interim phase I/II VSV-SARS-CoV2 vaccine experience.

Journal: Vaccine

Published: February 09, 2021

Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.

Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.

Journal: Cellular signalling

Published: December 16, 2015

Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations.

Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations.

Journal: PloS one

Published: July 13, 2013

A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.

A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.

Journal: The Journal of biological chemistry

Published: August 08, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026